Related Experiment Video
Updated: Jun 3, 2025

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application
Published on: June 16, 2023
Multi-layer platform coordination for open innovation in oligonucleotide therapeutics
Yayoi Kawata1, Taisuke Ichimaru2, Masakazu Kogami2
1Department of Innovation Science, School of Environment and Society, Institute of Science Tokyo, Japan.
Abstract:
As technology evolves and medical needs diversify, the pharmaceutical industry must accelerate its openness. This study analysed inter-organizational alliances in R&D for the new modality of oligonucleotide therapeutics to explore the requirements for establishing new markets. The results confirmed that the market has developed in stages, employing open innovation for different purposes according to technological progress. At each stage, it was crucial to form platforms among biotech companies on the drug discovery side, among pharmaceutical companies on the regulatory side and contract development manufacturing organizations (CDMOs) on the manufacturing side. These findings clarify the dynamics of open innovation in the biopharmaceutical industry and provide strategic implications for sustainable value creation in drug R&D.
More Related Videos
Related Concept Videos
Drug Discovery: Overview
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
Ligand Binding and Linkage
Cooperative Allosteric Transitions
Protein-protein Interfaces

